@dansfera: The *real* debate unfolding in drug evaluation: Is all that genomic profiling worth the hype, or does the final verdict truly hinge on hard numbers like overall survival and median duration of response? Discover the surprising focus one major health body head puts on tangible patient outcomes over personalized markers. Plus, there’s a crucial safety net: strict lab cutoffs ensuring patient organs and blood counts can tolerate the potential toxic effects of investigational drugs. A deep dive into what truly matters in determining drug efficacy and safety. 🤯 #Oncology #ClinicalTrials #DrugSafety #Biomarkers #MedTech

dansfera

Open In TikTok:

Region: US

Wednesday 10 December 2025 01:21:41 GMT